Journal article
Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response
- Abstract:
- Sepsis is a life-threatening condition involving a dysregulated immune response to infectious agents that causes injury to host tissues and organs. Current treatments are limited to early administration of antibiotics and supportive care. While appealing, the strategy of targeted inhibition of individual molecules in the inflammatory cascade has not proved beneficial. Non-targeted, systemic immunosuppression with steroids has shown limited efficacy and raises concern for secondary infection. Iminosugars are a class of small molecule glycomimetics with distinct inhibition profiles for glycan processing enzymes based on stereochemistry. Inhibition of host endoplasmic reticulum resident glycoprotein processing enzymes has demonstrated efficacy as a broad spectrum antiviral strategy, but limited consideration has been given to the effects on host glycoprotein production and consequent disruption of signaling cascades. This work demonstrates that iminosugars inhibit dengue virus, bacterial lipopolysaccharide, and fungal antigen stimulated cytokine responses in human macrophages. In spite of decreased inflammatory mediator production, viral replication is suppressed in the presence of iminosugar. Transcriptome analysis reveals the key interaction of pathogen-induced endoplasmic reticulum stress, the resulting unfolded protein response, and inflammation. Our work shows that iminosugars modulate these interactions. Based on these findings, we propose a new therapeutic role for iminosugars as treatment for sepsis related inflammatory disorders associated with excess cytokine secretion.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.1MB, Terms of use)
-
- Publisher copy:
- 10.1111/imm.13393
Authors
- Publisher:
- Wiley
- Journal:
- Immunology More from this journal
- Volume:
- 164
- Issue:
- 3
- Pages:
- 587-601
- Publication date:
- 2021-08-01
- Acceptance date:
- 2021-06-28
- DOI:
- EISSN:
-
1365-2567
- ISSN:
-
0019-2805
- Language:
-
English
- Keywords:
- Pubs id:
-
1187321
- Local pid:
-
pubs:1187321
- Deposit date:
-
2021-07-22
- ARK identifier:
Terms of use
- Copyright holder:
- Sayce et al.
- Copyright date:
- 2021
- Rights statement:
- © 2021 The Authors. Immunology published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record